Accessibility Menu
Encompass Health logo

Encompass Health

(NYSE) EHC

Current Price$112.24
Market Cap$11.13BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1986)+3,175%
5 Year+86%
1 Year+2%
1 Month+15%
Encompass Health last closing stock price
MetricPriceDate
Last closeUSD 112.212026-07-17
Encompass Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.86%USD 110.162026-07-10
1 month+14.84%USD 97.712026-06-17
3 month+5.67%USD 106.192026-04-17
Year to date+6.32%USD 105.542025-12-31
1 year+2.4%USD 109.582025-07-17
3 year+70.1%USD 65.972023-07-18
5 year+86.47%USD 60.172021-07-16
Since inception+3,175.33%USD 3.431986-09-24

Encompass Health Financials at a Glance

Market Cap

$11.13BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$6.07B

Net Income (TTM)

$609.20M

EPS (TTM)

$5.99

P/E Ratio

18.73

Dividend

$0.76

Beta (Volatility)

0.58 (Low)

Price

$112.24

Volume

37,382

Open

$112.80

Previous Close

$112.24

Daily Range

$111.40 - $114.47

52-Week Range

$92.77 - $127.99

Estimated Earnings Date

Aug 5, 2026

EHC: Motley Fool Moneyball Superscore

73

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Encompass Health

Encompass Health helps people recover from major injuries and illnesses in specialized hospitals. These facilities provide intensive therapy to help patients regain their independence and quality of life. The company also offers nursing and support services for patients in their own homes.

Helping Patients Recover

  • Inpatient Rehabilitation: Intensive therapy and 24-hour nursing care for people with complex conditions like strokes or brain injuries; provided 97% of net operating revenues in 2025.
  • Home Health: Skilled nursing and therapy services delivered to adult patients in their homes to support recovery.
  • Hospice: In-home care and support for terminally ill patients and their families.

Recent Strategic Moves

  • Opened 7 new inpatient rehabilitation hospitals during 2025 to expand service capacity.
  • Added 371 new beds to existing hospitals in 2025 to meet rising patient demand.
  • Held stroke-specific certifications at 148 hospitals as of December 31, 2025, to provide specialized clinical care.
  • Collaborated with the American Heart Association and American Stroke Association to improve nationwide stroke recovery outcomes.

What Makes the Company Stand Out

Encompass Health is the largest owner and operator of inpatient rehabilitation hospitals in the United States. Its scale allows it to use large clinical datasets and electronic medical records to improve patient outcomes and lower costs.

The Latest Financial Facts

  • Net operating revenues reached $5.9 billion in 2025, up 10.4% from 2024.
  • Net income rose to $146.1 million in Q4 2025, up 20.8% year-over-year.
  • Free cash flow hit $116.7 million in Q4 2025, up 45.7% from Q4 2024.
  • Operating cash flow reached $346 million in Q4 2025, up 24.1% from the previous year.
  • The company increased its total number of licensed beds to 11,465 by the end of 2025.

The Evolution of Care

Encompass Health has transitioned from a multi-service provider into a focused leader in facility-based rehabilitation. By expanding its hospital network and investing in specialized certifications, the company has aligned its operations with the needs of a growing aging population.

AI Generated • Apr 21, 2026

Industry

Healthcare Providers and Services

Employees

42,300

CEO

Mark J. Tarr, MBA

Headquarters

Birmingham, AL 35242, US

EHC Financials

Key Financial Metrics (TTM)

Gross Margin

58.82%

Operating Margin

17.93%

Net Income Margin

10.04%

Return on Equity

25.35%

Return on Capital

20.44%

Return on Assets

8.33%

Earnings Yield

5.34%

Dividend Yield

0.68%

Payout Ratio

12.05%

Stock Overview

Market Cap

$11.13BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

99.20M

Volume

37.38K

Avg. Volume

1.02M

Financials (TTM)

Gross Profit

$3.57B

Operating Income

$1.09B

EBITDA

$1.46B

Operating Cash Flow

$1.20B

Capital Expenditure

-$735.70M

Free Cash Flow

$464.40M

Cash & ST Invst.

$200.50M

Total Debt

$2.79B

Encompass Health Performance Analysis

Encompass Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 4,348,600,0008.3%
20232023-12-31USD 4,801,200,00010.4%
20242024-12-31USD 5,373,200,00011.9%
20252025-12-31USD 5,935,200,00010.5%
Encompass Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-300.2%
Q32025-09-301.4%
Q42025-12-314.5%
Q12026-03-312.7%
Encompass Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 2.70-34.4%
20232023-12-31USD 3.4728.7%
20242024-12-31USD 4.4628.3%
20252025-12-31USD 5.5424.2%
Encompass Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-6.1%
Q32025-09-30-10.8%
Q42025-12-3115.3%
Q12026-03-3135.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$1.59B

+9.0%

Gross Profit

$768.50M

+21.8%

Gross Margin

48.44%

N/A

Market Cap

$11.13BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$263.15K

N/A

Employees

42,300

N/A

Net Income

$194.50M

+28.4%

EBITDA

$407.80M

+16.6%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$200.50M

+109.3%

Total Debt

$2.79B

+3.2%

Accounts Receivable

$676.00M

+8.4%

Inventory

$0.00

N/A

Long Term Debt

$2.72B

+7.2%

Short Term Debt

$69.80M

-57.8%

Return on Assets

8.33%

N/A

Return on Invested Capital

16.90%

N/A

Free Cash Flow

$150.70M

+20.1%

Operating Cash Flow

$313.10M

+8.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RDYDr. Reddy's Laboratories Limited
$12.60-0.79%
ENSGThe Ensign Group, Inc.
$171.28-0.93%
ALGNAlign Technology, Inc.
$176.76-0.92%
UHSUniversal Health Services, Inc.
$151.16-1.55%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$6.53-0.02%
AALAmerican Airlines Group
$14.98-0.04%
NVDANvidia
$202.81-0.02%
NOKNokia
$10.12-0.03%

Questions About EHC

What is the current price of Encompass Health?

Encompass Health is trading at $112.24 per share.

What is the 52-week range for Encompass Health?

Over the past 52 weeks, Encompass Health has traded between $92.77 and $127.99.

How much debt does Encompass Health have?

As of the most recent reporting period, Encompass Health reported total debt of $2.79B.

How much cash does Encompass Health have on hand?

Encompass Health reported $163.40M in cash and cash equivalents in its most recent financial results.

What is Encompass Health’s dividend yield?

Encompass Health currently has a dividend yield of 0.68%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.